Skip to main content

Table 1 Characteristics of the T2D subjects before treatment

From: Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial

Patient no.

Age

Gender

Marriage

History (year)

BMI

Fasting glucose

HbA1C (%)

C-peptide (ng/ml)*

Group A: Long-standing patients having normal β cell function with oral medications

1

60

M

Yes

13

30.42

10.39

8.6

2.93

2

38

M

Yes

8

20.9

8.39

9.6

0.89

3

53

M

Yes

4

28.72

9.3

7.9

2.07

4

41

F

Yes

4

26.81

8.2

7.8

1.88

5

29

M

Yes

2

26.78

6.2

7.5

1.67

6

43

F

Yes

2

27.55

10.83

8.7

1.93

7

61

M

Yes

8

30.81

6.53

7.4

1.6

8

68

F

Yes

6

21.2

6.21

8.4

0.97

9

40

M

Yes

6

25.31

15.95

12.3

0.8

10

36

M

Yes

1

25.14

11.59

10.2

1.03

11

54

F

Yes

13

28.28

11.95

8.9

0.91

12

55

F

Yes

14

25.04

8.27

9.7

0.91

13

57

M

Yes

1

26.4

6.95

7.5

1.41

14

54

M

Yes

15

32.35

7.6

7.9

1.5

15

45

F

Yes

1

25

9.46

8.4

1.89

16

58

F

Yes

10

22.91

8.97

9.7

1.08

17

57

F

Yes

14

23.88

7.38

7.4

1.07

18

64

M

Yes

13

32.81

8.3

8.4

2.09

Mean

50

  

7.5

26.68

9.03

8.68

1.48

(SD)

(11)

  

(5)

(3.46)

(2.44)

(1.25)

(0.58)

Group B: Long-standing patients having normal β cell function with insulin injection

19

52

M

Yes

12

28.12

10.63

9.4

1.08

20

44

F

Yes

9

24.2

10.64

8.1

0.96

21

60

F

Yes

12

23.23

11.55

10.0

1.13

22

56

M

Yes

11

28.37

12.19

7.5

1.19

23

46

M

Yes

5

29.05

7.62

7.8

1.61

24

44

M

Yes

2

31.35

10.99

8.5

1.96

25

40

M

Yes

4

24.46

9.1

7.4

1.29

26

61

F

Yes

13

30.47

11.03

8.8

1.53

27

64

F

Yes

2

27.06

8.63

8.3

1.64

28

39

M

Yes

11

28.09

10.94

9.8

1.84

29

47

M

Yes

7

26.45

7.27

7.9

1.33

Mean

50

  

8

27.35

10.05

8.5

1.41

(SD)

(9)

  

(4)

(2.59)

(1.63)

(0.9)

(0.32)

Group C: Long-standing patients having impaired β cell function with insulin injection

30

66

F

Yes

18

22.48

10.71

8.3

0.39

31

39

M

Yes

3

19.83

8.0

13.2

0.45

32

55

F

Yes

24

22.27

6.77

7.3

0.16

33

54

M

Yes

15

25.69

8.56

8.5

0.59

34

49

F

Yes

15

24.22

10.15

9.6

0.17

35

54

M

Yes

11

27.72

8.02

8.9

0.56

36

47

M

Yes

15

24.28

9.18

11.1

0.19

Mean

52

  

14

23.78

8.77

9.56

0.36

(SD)

(8)

  

(6)

(2.56)

(1.36)

(1.99)

(0.19)

  1. * The levels of 0.6 to approximately 3.4 ng/ml are the normal ranges for Chinese fasting C-peptide by radioimmunoassay (RIA). To convert C-peptide value to nmol/L, multiply the ng/ml by 0.331.
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us